Trial intelligence / Profile preview

HSR and Corticosteroid Injection for Plantar Fasciopathy

NCT03535896Completed

Sponsor
Aalborg University
Start
Jun 2018
Primary completion
Oct 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label, single-arm trial of triamcinolone hexacetonide in plantar fasciitis, sponsored by Aalborg University. Primary endpoints: Acceptability of Combined Interventions at 8 weeks, Exercise Compliance at 8 weeks and 2 more. Started Jun 2018; status: completed.

02

Drugs

triamcinolone hexacetonide
03

Conditions

plantar fasciitis

Beyond the preview

Go deeper on NCT03535896.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03535896.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call